Clinical Trial Update: Study of SCB01A in Patient With Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for SCB01A in head and neck squamous cell carcinoma has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• SCB01A

Snippet

Sponsor: SynCore Biotechnology Co., Ltd. | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2023-06-27